← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

A

$ Value

$0

Shares

10,350

Price

$0

Filed

Jun 13

Insider

Name

Bedrosian Camille L

Title

CIK

0001326969

Roles

Director

Transaction Details

Transaction Date

2025-06-11

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,350

Footnotes

The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. | The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Filing Info

Accession No.

0000950170-25-086265

Form Type

4

Issuer CIK

0001658247

Bedrosian Camille L's History

Date Ticker Type Value
2025-12-01 AMLX $94K
2025-09-30 AMLX $176K
2025-06-24 RYTM A $0
2025-06-24 RYTM A $0
2025-06-18 RYTM M
2025-06-18 RYTM M $0
2025-06-11 CRNX A $0
2025-06-11 CRNX A $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08